ArticleCell biochemistry and biophysics2026
Association of Epithelial-to-Mesenchymal Transition Related Markers With Clinical Outcome in Non-Muscle Invasive and Muscle Invasive Bladder Cancer Patients.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Clinical significance of epithelial-to-mesenchymal transition (EMT)-related markers was evaluated in a cohort of NMIBC (non-muscle invasive bladder cancer) and MIBC (muscle invasive bladder cancer) patients. Real-time quantitative polymerase chain reaction (RT-qPCR) and immunohistochemical (IHC) staining were carried out in 100 tumor specimens [59 NMIBC and 41 MIBC]. The expressions of the epithelial marker, mesenchymal markers and EMT-activating transcription factors (EMT-ATFs) were determined at mRNA and protein level followed by their statistical associations with clinicohistopathological variables of the patients. Expression of E-cadherin at mRNA level exhibited significant association with tumor type in NMIBC cohort and with age of MIBC patients. Association of mRNA levels of N-cadherin was reported with smoking/tobacco chewing status (S/TC) of NMIBC patients and with tumor type in MIBC cohort. Membranous expression of Vimentin protein showed significance with age of MIBC patients. Gene expression of Snail showed relevance with tumor type and S/TC status of NMIBC patients whereas its protein (nuclear) expression exhibited significance with tumor grade in NMIBC cohort. Nuclear expression of Slug showed significance with S/TC status of NMIBC patients. The study reported significances of gene levels of Twist with tumor stage and age of MIBC patients while its protein (nuclear) expression with tumor grade in NMIBC cohort. Zeb-1 mRNA levels exhibited statistical relevance with tumor stage while its protein (nuclear) expression with tumor grade in NMIBC patients. Survival analysis identified Vimentin as the predictor of short progression free survival (PFS) and short overall survival (OS) in MIBC patients. Study established altered EMT profile as an independent predictor of short recurrence free survival (RFS) in NMIBC patients and of short PFS and OS in MIBC patients. Observed significances of EMT-related markers with patients' clinicohistopathological variables as well as with their survival outcome may strengthen risk stratification and hence could be of importance in the clinical management of bladder cancer patients.
Indexed as
Identifiers
42348111What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.